Skip to main content
Log in

Terminology of torsades de pointes

  • Forum on Torsades de Pointes Part Three
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Marked prolongation of the QT interval may be associated with life-threatening ventricular tachycardia. The ventricular tachycardia has a polymorphous appearance and is usually induced by antiarrhythmic drugs. This peculiar type of ventricular tachycardia was termed by Desserstennetorsades de pointes because of its twisting ORS axis. The main reason to give this entity a special name that differentiates it from other types of ventricular tachycardia is the unique therapeutic approach to its treatment. Torsades de pointes can be suppressed by interventions that shorten the QT interval by increasing the heart rate, such as ventricular or atrial pacing, isoproterenol infusion, or atropine. Recently intravenous magnesium was also shown to be extremely effective. If torsades de pointes is treated as a conventional ventricular tachycardia by drugs that may further prolong the QT interval, it may lead to fatal results. To draw the attention of physicians to this unusual form of ventricular tachycardia, we suggest that the term torsades de pointes be kept. This specific diagnosis will hopefully guide the treating physician in selecting the appropriate mode of therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Selzer A, Wray HW. Quinidine syncope: Paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias.Circulation 1964;30:17–26.

    PubMed  CAS  Google Scholar 

  2. Dessertenne F. La tachycardie ventriculaire a deux foyers opposes veriables.Arch Mal Coeur 1966;59:263–272. (For English translation, seeCardiovasc Drugs Therap 1990;4: 1171–1176.)

    PubMed  CAS  Google Scholar 

  3. Krikler DM, Curry PVL. Torsades de pointes, an atypical ventricular tachycardia.Br Heart J 1976;38:117–120.

    Article  PubMed  CAS  Google Scholar 

  4. Sclarovsky S, Strasberg B, Lewin RF, Agmon J. Polymorphous ventricular tachycardia: Clinical features and treatment.Am J Cardiol 1979;44:339–344.

    Article  Google Scholar 

  5. Keren A, Tzivoni D, Gavish A, et al. Etiology, warning signs and therapy of torsades de pointes: A study of 10 patients.Circulation 1981;64:1167–1174.

    PubMed  CAS  Google Scholar 

  6. Tzivoni D, Keren A, Stern S, Gottlieb S. Atypical ventricular tachycardia induced bv disopyramide.Arch Intern Med 1981;141:946–947.

    Article  PubMed  CAS  Google Scholar 

  7. Strasberg B, Sclarovsky S, Edberg A, et al. Procainamide induced polymorphous ventricular tachycardia.Am J Cardiol 1981;47:1309–1314.

    Article  PubMed  CAS  Google Scholar 

  8. Horowitz LN, Greenspan AM, Spielman SR, Josephson ME. Torsades de pointes: Electrophysiological studies in patients without transient pharmacologic or metabolic abnormalities.Circulation 1981;63:1120–1128.

    PubMed  CAS  Google Scholar 

  9. Garan H, Fallon JT, Ruskin JN. Nonsustained polymorphic ventricular tachycardia induced by electrical stimulation in 3 week old canine myocardial infarction.Am J Cardiol 1981;48:280–286.

    Article  PubMed  CAS  Google Scholar 

  10. Anderson JL, Mason JW. Successful treatment by overdrive pacing of recurrent quinidine syncope due to ventricular tachycardia.Am J Med 1978;64:715–718.

    Article  PubMed  CAS  Google Scholar 

  11. Keren A, Tzivoni D, Golhman JM, et al. Ventricular pacing in atypical ventricular tachycardia.J Electrocardiol 1981; 14:201–206.

    Article  PubMed  CAS  Google Scholar 

  12. Tzivoni D, Keren A, Cohen AM, et al. Magnesium therapy for torsades de pointes.Am J Cardiol 1984;53:528–530.

    Article  PubMed  CAS  Google Scholar 

  13. Tzivoni D, Banai S, Schuger C, et al. Treatment of torsades de pointes with magnesium sulfate.Circulation 1988;77: 392–397.

    PubMed  CAS  Google Scholar 

  14. Bailie DS, Inoue H, Kaseda S, et al. Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs.Circulation 1988;77: 1395–1402.

    PubMed  CAS  Google Scholar 

  15. Davidenko JM, Cohen L, Gooddrow R, Antzelevitch C. Quinidine induced action potential prolongation, early after-depolarization, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium and magnesium.Circulation 1989;79:674–686.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tzivonir, D., Keren, A., Banai, S. et al. Terminology of torsades de pointes. Cardiovasc Drug Ther 5, 505–507 (1991). https://doi.org/10.1007/BF03029777

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03029777

Key Words

Navigation